Lazard Transactions
DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided
Download results
Showing 1 to 10 of 1310 Results
March 20, 2026
Falfurrias Launches Crosslakes Next Growth Phase Through Single-Asset Continuation Fund Led by Leonard Green & Partners
Undisclosed
March 16, 2026
Paratek Pharmaceuticals Completes Combination with Radius Health, Expanding Its MultiProduct Specialty Commercial Platform
$1.3 Billion
February 06, 2026
$9.4bn rights issue proceeds with 99.3% initial take-up and additional over-subscriptions
$9.4 Billion
February 06, 2026
Ørsted announces plan for a rights issue with support from the Danish State as majority shareholder and gross proceeds of DKK 60 billion
$9.3 Billion
January 26, 2026
Oviva Secures €200 Million to Expand AI-Enabled Healthcare Across Europe
$234 Million
January 21, 2026
GPS Group in Major €300 Million Infrastructure Refinancing
$348.9 Million
January 21, 2026
Black Bay Partners Closes Third Fund at $425 Million Hard Cap
$425 Million
December 30, 2025
Lazard acted as financial advisor to Naviam on the refinancing of its senior facilities
Undisclosed
December 18, 2025
Eir Partners Closes Oversubscribed Fund III at $1 Billion
$1 Billion
December 02, 2025